Healthy middle-aged and older population.
Conditions
Interventions
Placebo (Casein) ingestion, 8 weeks
Lactotripeptides ingestion (4.8 mg/d), 8weeks
Placebo (Casein) ingestion, 8 weeks Aerobic exercise (Moderate intensity, 30-50 min, 4-6 d/w), 8weeks
Lactotripepti
Sponsors
University of Tsukuba, Faculty of Health and Sport Sciences, Division of Sport Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 50 years and older men, postmenopausal women, not restricted by a doctor from exercising, not have medication, smoking, and exercise habits
Exclusion criteria
Exclusion criteria: Have a cardiovascular and cerebrovascular disease, lactose intolerance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebral hemodynamics (8 week after intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial stiffness (8 week after intervention) | — |
Countries
Japan
Contacts
Public ContactNobuhiko Akazawa
University of Tsukuba Faculty of Health and Sport Sciences
Outcome results
None listed